Sensory neuron–expressed FGF13 controls nociceptive signaling in diabetic neuropathy models

Journal:
Journal of Clinical Investigation
Published:
DOI:
10.1172/jci183749
Affiliations:
21
Authors:
50
Institutions Authors Share
University of Texas Medical Branch (UTMB), United States of America (USA)
27.000000
27.000000
27.000000
0.54
University of Cincinnati (UC), United States of America (USA)
4.000000
0.08
IRCCS Carlo Besta Neurological Institute, Italy
3.500000
0.07
Center for Advanced Pain Studies (CAPS), UT Dallas, United States of America (USA)
3.000000
0.06
University of Houston (UH), United States of America (USA)
3.000000
0.06
Anatomic Incorporated, United States of America (USA)
2.000000
0.04
NIH Clinical Center, United States of America (USA)
2.000000
0.04
Maastricht University Medical Center+ (Maastricht UMC+), Netherlands
1.000000
0.02
University of Bari Aldo Moro (UniBA), Italy
1.000000
0.02
German Diabetes Center - Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf (DDZ), Germany
1.000000
0.02
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
0.02
University of Milan (UNIMI), Italy
0.500000
0.01
NIHR/Wellcome Trust Clinical Research Facility, MFT, United Kingdom (UK)
0.250000
0.01
The University of Manchester (UoM), United Kingdom (UK)
0.250000
0.01
Weill Cornell Medicine-Qatar (WCM-Q), Cornell University, Qatar
0.250000
0.01
Qatar Foundation, Qatar
0.250000
0.01